Epithelial-to-mesenchymal transition antagonizes response to targeted therapies in lung cancer by suppressing BIM.

about

Epithelial-to-mesenchymal transition antagonizes response to targeted therapies in lung cancer by suppressing BIM.

Item

http://www.wikidata.org/entity/Q45070526

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Epithelial-to-mesenchymal tran ...... ung cancer by suppressing BIM.

@en

Epithelial-to-mesenchymal tran ...... ung cancer by suppressing BIM.

@nl

type

Item

label

Epithelial-to-mesenchymal tran ...... ung cancer by suppressing BIM.

@en

Epithelial-to-mesenchymal tran ...... ung cancer by suppressing BIM.

@nl

prefLabel

Epithelial-to-mesenchymal tran ...... ung cancer by suppressing BIM.

@en

Epithelial-to-mesenchymal tran ...... ung cancer by suppressing BIM.

@nl

P1476

Epithelial-to-Mesenchymal Tran ...... Lung Cancer by Suppressing BIM

@en

P2093

Aaron N Hata

http://www.w3.org/2001/XMLSchema#string

Angel Garcia

http://www.w3.org/2001/XMLSchema#string

Anthony C Faber

http://www.w3.org/2001/XMLSchema#string

Brad E Windle

http://www.w3.org/2001/XMLSchema#string

Bradley Bernstein

http://www.w3.org/2001/XMLSchema#string

Daniel A R Heisey

http://www.w3.org/2001/XMLSchema#string

Elizabeth L Lockerman

http://www.w3.org/2001/XMLSchema#string

Haichuan Hu

http://www.w3.org/2001/XMLSchema#string

Hannah L Archibald

http://www.w3.org/2001/XMLSchema#string

Hidenori Kitai

http://www.w3.org/2001/XMLSchema#string

P2860

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome

Model-based analysis of ChIP-Seq (MACS)

Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer models

ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL

Epithelial-mesenchymal plasticity in carcinoma metastasis

The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics

Structural insights into the degradation of Mcl-1 induced by BH3 domains

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

P304

197-208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-17-1577

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hiromichi Ebi

Mikhail G Dozmorov

Yotam Drier

Konstantinos V Floros

Timothy L Lochmann

P577

2017-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29051323

http://www.w3.org/2001/XMLSchema#string

P932

5959009

http://www.w3.org/2001/XMLSchema#string